stars 1 stars 2 stars 3

Millions of people live with wounds that won’t heal. These wounds limit mobility, cause pain, and take away independence. Current treatments are often slow, expensive, and frustrating — for patients, caregivers, and healthcare systems alike. At Plasmacure, we’re changing that. Our patented cold plasma system, PLASOMA, is the first solution proven to close chronic wounds faster, safer, and more effectively. Clinically validated In a randomized controlled trial, PLASOMA was shown to be 2.5x more effective than traditional wound care. Cuts costs, boosts efficiency Treatment with PLASOMA can reduce healthcare costs by more than 40% and free up clinicians’ time by more than 50%. Fast and easy Each session takes just two minutes and fits easily into existing care routines. Safe in clinic and at home PLASOMA is currently the only cold plasma wound care solution proven safe and effective for both in-clinic and home use, validated through a peer-reviewed RCT. With a CE-marked Class IIb medical device already on the market, we are expanding across Europe and preparing entry into the United States and China.

Plasmacure Questions

Bjorn Sprengers is the CEO of Plasmacure.

12 people are employed at Plasmacure.

Top Plasmacure Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users